Position in PFE
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$346,365
-$36,674 QoQ
Shares Held
14,384
+5.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#2,020
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Winthrop Advisory Group LLC holds $8,653,027 across 8 Drug Manufacturers - General names. PFE ranks #6 (4.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
10,894 | $2,766,749 | |
| 2 | LLY |
ELI LILLY & Co
|
1,928 | $2,312,500 | |
| 3 | ABBV |
AbbVie Inc.
|
4,944 | $1,244,107 | |
| 4 | MRK |
Merck & Co., Inc.
|
7,931 | $1,019,133 | |
| 5 | AMGN |
Amgen Inc
|
1,052 | $380,949 | |
| 6 | PFE |
Pfizer Inc
This page
|
14,384 | $346,365 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
2,429 | $306,879 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
4,796 | $276,345 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $346,365 | 14,384 | Shares | Sole | 2026-07-17 | |
| 2026-03-31 | $383,039 | 13,641 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $377,956 | 15,179 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $350,936 | 13,773 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $344,498 | 14,212 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $377,287 | 14,889 | Shares | Sole | 2025-04-08 | |
| 2024-12-31 | $411,506 | 15,511 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $458,235 | 15,834 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $431,927 | 15,437 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $429,320 | 15,471 | Shares | Sole | 2024-04-17 | |
| 2023-12-31 | $457,300 | 15,884 | Shares | Sole | 2024-01-10 | |
| 2023-09-30 | $557,554 | 16,809 | Shares | Sole | 2023-11-03 | |
| 2023-06-30 | $647,952 | 17,665 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $725,016 | 17,770 | Shares | Sole | 2023-08-01 | |
| 2022-12-31 | $952,346 | 18,586 | Shares | Sole | 2023-08-03 | |
| 2022-09-30 | $752,672 | 17,200 | Shares | Sole | 2022-11-04 | |
| 2022-06-30 | $815,129 | 15,547 | Shares | Sole | 2022-07-21 | |
| 2022-03-31 | $805,748 | 15,564 | Shares | Sole | 2022-04-13 | |
| 2021-12-31 | $892,363 | 15,112 | Shares | Sole | 2022-01-12 | |
| 2021-09-30 | $648,977 | 15,089 | Shares | Sole | 2021-10-14 | |
| 2021-06-30 | $561,162 | 14,330 | Shares | Sole | 2021-07-14 | |
| 2021-03-31 | $544,754 | 15,036 | Shares | Sole | 2021-04-23 | |
| 2020-12-31 | $619,254 | 16,823 | Shares | Sole | 2021-01-25 | |
| 2020-09-30 | $533,727 | 14,543 | Shares | Sole | 2020-10-20 | |
| 2020-06-30 | $402,766 | 12,317 | Shares | Sole | 2020-07-17 | |
| 2020-03-31 | $401,308 | 12,295 | Shares | Sole | 2020-04-17 | |
| No filing history on record for this holder in this stock. | ||||||